Abstract:
A series of octahedral Co III salen complexes (where salen represents a N 2 O 2 bis-Schiff-base bisphenolate framework) were prepared with axial imidazole ligating groups. When using 1-methylimidazole (1-MeIm) axial ligands, the Co III / Co II reduction potential could be altered by 220 mV via variation of the electron-donating ability of the para-ring substituents (R = H (1), OMe (2), tBu (3), Br (4), NO 2 (5), and CF 3 (6) ). In addition, the irreversibility of the reduction process suggested substantial geometrical changes and axial ligand exchange upon reduction to the more labile Co II oxidation state. Installing an imidazole-coumarin conjugate as the axial ligands resulted in fluorescence quenching when bound to the Co III centre (R = H (7), OMe (8) ,
and CF 3 (9) ). The redox properties and fluorescence increase upon ligand release for 7-9 were studied under reducing conditions, and in the presence of excess competing ligand (1-MeIm). It was determined that the Lewis acidity of the Co III centre was the dominant factor in controlling axial ligand exchange for this series of complexes.
D r a f t
Introduction:
There is an increasing interest in metal-based drugs for diagnostic and therapeutic applications, due to the need to increase both potency and selectivity. [1] [2] [3] [4] [5] The ability to vary the coordination number, geometry, redox states, and overall charge provide major design advantages to metal-based over organic-based drugs. In addition, the ligand(s) play a key role in determining the pharmacokinetic properties of metal-containing drugs, allowing for tuning of the complex to increase efficacy. 6 Metal complexes have been extensively studied as anticancer agents, with the development of Cisplatin playing an instrumental role in bringing medicinal inorganic chemistry into the mainstream. 7 In certain cases, the ligand(s) can also be active drugs, and complexation to a metal complex can provide a means for selective delivery and/or activation. 8 Metal complexes are well-suited as tumour-selective drug delivery agents, and can be activated by environmental factors such as pH, 9-10 redox, 11 and light. [12] [13] The work herein focuses on the utilization of redox changes for metal complex activation.
A number of transition metal ions exhibit changes in geometrical preference and/or lability in different oxidations states, and these features have been exploited in the design of metal complexes that undergo selective activation in environments with different redox states. In the case of cancer, solid tumours exhibit a reduced O 2 supply, which in combination with elevated levels of reducing agents and reductase enzymes results in a hypoxic microenvironment. [14] [15] [16] A number of metal-based pro-drugs have been developed to target hypoxic tumour tissues, including complexes of Pt IV , Ru III , and Co III (Figure 1) . 8, 11, 17 Reduction of the Pt IV complex Satraplatin ( Figure 1A ) produces the activated Pt II species. Reduction of the Ru III complex NKP1339 ( Figure 1B ) 18 to Ru II is hypothesized as one mode of activation for this important class of anticancer agents, 19 24 and curcumin. 25 A key feature of these complexes, and other bioreductive pro-drugs, is the ability to tune the reduction potential so that activation occurs selectively under hypoxic conditions in a tumour. 26 The approximate cellular reduction potential is estimated to be between -420 to -150 mV (vs. NHE), 27 and the reduction potential of a tumour is usually at the lower end of this range. 28 Previously, we showed that it is possible to tune the reduction potential of metal salen (salen represents an N 2 O 2 bis-Schiff-base bis-phenolate framework., Figure 1D ) complexes over a large range via alteration of the para-ring substituents, [29] [30] [31] [32] and we have now extended this work to a series of octahedral Co III salen complexes ( Figure 1D ). It was hypothesized that bioreduction to Co II would lead to significant geometrical rearrangement and axial ligand exchange (loss of L in Figure 1D ), thus providing a selective release mechanism for cytotoxic ligands in the axial position. In addition, a number of reports have demonstrated the cytotoxicity of Co II salen complexes, a product of the reduction process. Source (ALS), Lawrence Berkeley National Laboratory using synchrotron radiation tuned to λ = 0.7749 Å. Intensity data were collected at 296 K on a D8 goniostat equipped with a Bruker APEXII CCD detector at Beamline 11.3.1. For data collection, frames were measured for a duration of 1 s at 0.3° intervals of ω with a maximum 2θ value of 60°. The data frames were collected using the program APEX2 and processed using the program SAINT within APEX2.
The data were corrected for absorption and beam corrections based on the multiscan technique as implemented in SADABS. The structure was solved by the intrinsic phasing method 40 and D r a f t subsequent refinements were performed using ShelXle. 41 For all structures non-hydrogen atoms were refined anisotropically. All C−H hydrogen atoms were placed in calculated positions but were not refined. A summary of the crystal data and experimental parameters for the structure determinations are given in [ Figures S3-S8) . Thus axial ligand exchange occurs relatively slowly for 1-4 under the test conditions. Interestingly, for the R = NO 2 (5) and R = CF 3 (6) derivatives no ligand exchange is observed at 24 h by 1 H NMR, indicating that the complexes with electron-withdrawing para-ring substituents are more stable to axial ligand exchange. The increased stability is likely due to the enhanced Lewis acidity of the Co III centre as a result of the electron-withdrawing effect of these para-ring substituents. were assessed via cyclic voltammetry (CV) to better understand how the different parasubstituents shift the Co III / Co II reduction potential. As shown in Figure 3 and Table 3 there is a large value of ∆E p (peak-to-peak difference, ∆E p = |E a -E c |) and a different current response for the reduction (E c ) and oxidation (E a ) processes. These results support an irreversible electrochemical process for 1-6, and thus reduction (E c ) suggests significant geometrical re-arrangement, including axial ligand loss to afford a Co The trend in reduction potential (E 1/2 ) for 1-6 follows the relative electronic properties of the phenolate para-substituents since the donating para-ring substituents afford a lower Co III / Co II reduction potential due to the increased electron density at the Co centre. Overall, using the different para-ring substituents allows for tuning of the E 1/2 value from -140 mV to 80 mV (220 mV difference), and E c value from -570 mV to -230 mV (340 mV difference). Plotting the E 1/2 values against the Hammett substituent constants (σ para ) [51] [52] as shown in Figure 3 (Inset) demonstrates that the reduction potential is predominantly affected by the donating ability of the para-ring substituents. These promising results show that it is possible to significantly alter the Co III / Co II reduction potential and, in addition, reduction leads to significant geometrical rearrangement and axial ligand loss.
Synthesis and Characterization of [Co
The synthesis of 7-9 followed closely to that of 6, using a one-pot procedure to first synthesize the Co incorporating the ClO 4 -counterion, however, the resulting products were difficult to purify and exhibited limited solubility in water. Employing CoCl 2 as the starting material, and without addition of NaClO 4 , we were able to isolate 7-9 in moderate yields (Scheme 2). These three complexes span a large range of electron-donating abilities (OMe, H, and CF 3 ), thus affording a representative series of complexes for further analysis. (Figures S11-S13 ).
Electrochemistry of [Co
The electrochemical properties of 7-9
were assessed via CV to determine reduction potentials and possibility of axial ligand loss upon reduction. As shown in Figure 5 and Table 4 , complexes 7-9 exhibit a large value of ∆E p and a different current response for the reduction (E c ) and oxidation (E a ) processes. These results We next assessed the use of fluorescence to monitor the rate of ligand loss from compounds 7-9 upon reduction in solution.
The photophysical properties of the Coumarin ligand were first investigated, with an optimal excitation wavelength (λ ex ) of 327 nm and emission wavelength (λ em ) of 400 nm ( Figure S14 ).
Upon binding to the Co III centre the Coumarin ligand emission is quenched (Figure 6 ), likely due to excited state energy-transfer. [53] [54] [55] A fluorescence signal is observed however for the R=H The ligand exchange processes of 7-9 were studied in the presence of excess dithionite (Na 2 S 2 O 4 ). The reduction potential for dithionite (E 1/2 = -660 mV vs. NHE) 56 is considerably lower than 7-9 ( Table 4) , and thus we expected this reagent to reduce the Co III complexes. As this reagent readily reacts with O 2 in solution, solutions were degassed (purging with N 2 ) before a 10-fold excess of Na 2 S 2 O 4 was added to ensure reduction of 7-9. [56] [57] [58] We then compared the decomposes, the observed fluorescence increase is likely a combination of both reduction and axial ligand exchange.
Summary:
In this work we have studied the electrochemical properties and axial ligand exchange of a series Future work will focus on decoupling these competing processes for this series of complexes.
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